Author:
Hartmann Markus,Schaffner Patricia
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference49 articles.
1. International Conference on Harmonisation. General Considerations for Clinical Trials E8. July 17, 1997. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E8/Step4/E8_Guideline.pdf. Accessed December 10, 2012.
2. International Conference on Harmonisation. Guideline for Good Clinical Practice E6(R1). June 10, 1996. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/Step4/E6_R1__Guideline.pdf. Accessed December 10, 2012.
3. Decoster G, Buyse M. Clinical research after drug approval: what is needed and what is not. Drug Inf J. 1999;33:627–634.
4. Glasser SP, Salas M, Delzell E. Importance and challenges of studying marketed drugs: what is a phase IV study? Common clinical research designs, registries, and self-reporting systems. J Clin Pharmacol. 2007;47:1074–1086.
5. Dreyer NA, Tunis SR, Berger M, et al. Why observational studies should be among the tools used in comparative effectiveness research. Health Aff. 2010;29:1–8.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献